Dr. Mark P. Dunphy, DO
- Medicare services, 2024
- 699
- Medicare patients, 2024
- 702
- Part D claims, 2023
- 11
- Publications
- 63
- Clinical trials
- 6
- Practice address
- 1275 York Avenue, New York, NY 10065
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Dunphy's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mark P. Dunphy is a nuclear medicine physician in New York, New York
Dr. Dunphy practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.
Dr. Dunphy's NPI, 1275552630, was assigned on July 18, 2006. Dr. Dunphy graduated from Michigan State University College Of Osteopathic Medicine in 2000. Dr. Dunphy holds New York license 225467.
- NPI
- 1275552630NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3779587621
- NPI enumeration date
- July 18, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 52
- Medical school graduation
- 2000
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mark P. Dunphy practices at Memorial Sloan Kettering Cancer Center in New York, New York
Dr. Dunphy's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.
- Memorial Sloan Kettering Cancer Center1275 York Avenue, New York, NY 10065
Source: Dmand AI Affiliation Data
Dr. Mark P. Dunphy is affiliated with 6 sites of care and 5 medical groups
Dr. Dunphy's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Nuclear Medicine Group. Dmand AI also links Dr. Dunphy to 5 more group practices and clinics and 4 medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Mark P. Dunphy's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dunphy practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Memorial Sloan Kettering Cancer Center | Available with a free account |
| +5 more sites and 4 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mark P. Dunphy is one of 59 nuclear medicine physicians in New York
Nuclear medicine is Dr. Dunphy's primary specialty in the NPI Registry, under taxonomy code 207U00000X. Dr. Dunphy is board certified in nuclear medicine by the American Board of Nuclear Medicine. Dr. Dunphy is licensed in New York.
Specialties and state licenses
- Nuclear medicine, New YorkPrimary
Nuclear medicine physicians near Dr. Dunphy
Counts of nuclear medicine physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mark P. Dunphy billed Medicare for 699 services in 2024
CMS data shows 699 Medicare services from Dr. Dunphy across 5 procedure codes in 2024, for 702 Medicare patients. Medicare paid $61,717 for them.
Dr. Dunphy's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Imaging
- 2023: 7842024: 68313%
- Office and hospital visits
- 2023: 672024: 1676%
Where Dr. Dunphy's Medicare services took place, 2024
- In an office43562%
- In a facility26438%
Dr. Dunphy compared with the New York median for nuclear medicine physicians, 2024
- Dr. Dunphy
- New York median
- Medicare services
- 699vs 78811% below
- Medicare patients
- 702vs 6488% above
- Part D claims
- 11vs 128% below
Medians across 61 nuclear medicine physicians in New York with Dmand AI profiles that report each measure.
Dr. Dunphy's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Dunphy?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Dunphy and other nuclear medicine physicians in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mark P. Dunphy treated 702 Medicare patients in 2024, average age 75
CMS counts 702 Medicare patients who saw Dr. Dunphy in 2024. The largest group is 65 to 74, with 311 patients. 75% of them have cancer, and 75% have high blood pressure. 9% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Dunphy's median patient age at 69, with 35% women.
Dr. Dunphy's Medicare patients by age, 2024
Dr. Dunphy's Medicare patients by sex, 2024
- Women21030%
- Men49270%
Chronic conditions among Dr. Dunphy's Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol75%
- Arthritis46%
- Ischemic heart disease43%
- Diabetes32%
- Anxiety31%
- Mood disorders25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Dunphy's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women35%
- Men64%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mark P. Dunphy wrote 11 Medicare Part D claims in 2023
In 2023, Dr. Dunphy wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $79 in total drug cost.
Dr. Dunphy's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
Dr. Mark P. Dunphy scored 91 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Dunphy for performance year 2024, reported as part of a group. Dr. Dunphy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dunphy as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Dunphy's MIPS scores, performance year 2024
- 91of 100Final score
- 84of 100Quality
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mark P. Dunphy has 63 publications on record
Dmand AI links 63 papers to Dr. Dunphy, published from 2012 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Radiopharmaceuticals, Fluorodeoxyglucose F18 and Positron-Emission Tomography. Dr. Dunphy has published most often in J Nucl Med. Dr. Dunphy's most frequent co-authors are Jason E. Lewis, DO, Wolfgang Weber, MD and Komal Jhaveri.
Dr. Dunphy's papers by year, 2015 to 2025
Topics Dr. Dunphy writes about most
- Radiopharmaceuticals
- Fluorodeoxyglucose F18
- Positron-Emission Tomography
- Positron Emission Tomography Computed Tomography
- Lung Neoplasms
- Brain Neoplasms
- HSP90 Heat-Shock Proteins
- Tissue Distribution
Dr. Dunphy's most frequent co-authors
Recent publications by Dr. Dunphy
See who Dr. Dunphy researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Dunphy works with, so you can find a warm path to the right nuclear medicine physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mark P. Dunphy has worked on 6 clinical trials
Dmand AI links Dr. Dunphy to 6 clinical trials, 2 of them early phase 1 studies. 4 are still active or recruiting. Conditions studied include Alzheimer Disease, Brain Neoplasms and Lymphoma. Memorial Sloan Kettering Cancer Center sponsors the most, 5.
Clinical trials with Dr. Dunphy by phase
- 2Early phase 1: 2 trials
- 2Phase 1: 2 trials
- 1Phase 1/2: 1 trial
- NonePhase 2: no trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Dunphy's trials
- Alzheimer Disease
- Brain Neoplasms
- Lymphoma
- Neoplasms, Plasma Cell
- Sarcoma
Investigators on the most trials with Dr. Dunphy
Recent clinical trials with Dr. Dunphy
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56 (opens in a new tab)
PET and MRI Imaging of Brain Tumors Using [18F]PARPi (opens in a new tab)
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative (opens in a new tab)
A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Mark P. Dunphy graduated from Michigan State University College Of Osteopathic Medicine
Dr. Dunphy graduated from Michigan State University College Of Osteopathic Medicine in 2000. Dr. Dunphy is a member of AOA.
- Medical school
- Board certified in nuclear medicine
- Board certified in 2007 - 2027
- Board certified in 2002 - 2025
- Board certified in 2001 - 2002
Source: Dmand AI Professional Profile Data
Dr. Mark P. Dunphy accepts plans from 5 insurance carriers
Dr. Dunphy is in network with 5 carriers, including Excellus BlueCross BlueShield, MVP Health Care and Aetna. EPO plans come from the most carriers, 2. Check the plan with the practice before a visit.
- Excellus BlueCross BlueShield
- MVP Health Care
- Aetna
- CMS Medicare
- NY State Medicaid
Plan types Dr. Dunphy accepts, by number of carriers
- EPO2
- Medicare2
- POS2
- PPO2
- HMO1
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Mark P. Dunphy's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mark P. Dunphy
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mark P. Dunphy's NPI number?
Dr. Mark P. Dunphy's NPI number is 1275552630. It was assigned on July 18, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Mark P. Dunphy?
Dr. Mark P. Dunphy is a nuclear medicine physician in New York, New York. The primary specialty in the NPI Registry is Nuclear Medicine Physician (taxonomy code 207U00000X).
Where does Dr. Mark P. Dunphy practice?
Dr. Dunphy practices at 1275 York Avenue, New York, NY 10065. Dr. Dunphy's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Dunphy to 5 group practices and clinics and 4 medical groups.
What is Dr. Mark P. Dunphy's medical license number?
Dr. Dunphy holds New York license 225467.
Which hospitals is Dr. Mark P. Dunphy affiliated with?
Dr. Dunphy practices at Memorial Sloan Kettering Cancer Center in New York, New York.
What medical group is Dr. Mark P. Dunphy part of?
Dr. Dunphy is linked to Memorial Nuclear Medicine Group. Dmand AI links Dr. Dunphy to 4 more medical groups.
Does Dr. Mark P. Dunphy accept Medicare?
Yes. CMS data shows Dr. Dunphy billed Medicare for 699 services in 2024, and Dr. Dunphy accepts Medicare assignment.
Does Dr. Mark P. Dunphy offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Dunphy as offering telehealth services.
What is Dr. Mark P. Dunphy's MIPS score?
Dr. Dunphy's MIPS final score for performance year 2024 is 91 out of 100, reported as part of a group.
How many Medicare patients does Dr. Mark P. Dunphy see?
CMS counts 702 Medicare patients who saw Dr. Dunphy in 2024, with an average age of 75.
Show 8 more questionsShow fewer questions
Is Dr. Mark P. Dunphy board certified?
Yes. Dr. Dunphy is board certified in nuclear medicine by the American Board of Nuclear Medicine.
What services does Dr. Mark P. Dunphy bill to Medicare?
In 2024, Dr. Dunphy's most billed Medicare services were nuclear medicine (78815), nuclear medicine (78816) and nuclear medicine (79101).
Where did Dr. Mark P. Dunphy go to medical school?
Dr. Dunphy graduated from Michigan State University College Of Osteopathic Medicine in 2000.
What drugs does Dr. Mark P. Dunphy prescribe most?
In 2023 Medicare Part D data, Dr. Dunphy's most prescribed drugs by claims were Dexamethasone.
How long has Dr. Mark P. Dunphy been practicing?
Dr. Dunphy graduated from medical school in 2000, 26 years ago.
Does Dr. Mark P. Dunphy do research?
Dmand AI links 63 publications to Dr. Dunphy, published from 2012 to 2025. Dr. Dunphy has worked on 6 clinical trials.
Who does Dr. Mark P. Dunphy publish with?
Dr. Dunphy's most frequent co-authors are Jason E. Lewis, DO (8 shared papers), Wolfgang Weber, MD (7 shared papers) and Komal Jhaveri (6 shared papers).
What insurance does Dr. Mark P. Dunphy accept?
Dr. Dunphy is in network with 5 carriers, including Excellus BlueCross BlueShield, MVP Health Care and Aetna. EPO plans come from the most carriers, 2. Check the plan with the practice before a visit.
Selling to nuclear medicine practices?
See nuclear medicine physicians in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card